Cerus EBITDA 2010-2024 | CERS

Cerus ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Cerus Annual EBITDA
(Millions of US $)
2024 $-12
2023 $-27
2022 $-31
2021 $-46
2020 $-55
2019 $-64
2018 $-54
2017 $-56
2016 $-60
2015 $-59
2014 $-43
2013 $-28
2012 $-17
2011 $-15
2010 $-15
2009 $-23
Cerus Quarterly EBITDA
(Millions of US $)
2024-12-31 $-1
2024-09-30 $-1
2024-06-30 $-3
2024-03-31 $-7
2023-12-31 $2
2023-09-30 $-5
2023-06-30 $-11
2023-03-31 $-14
2022-12-31 $-9
2022-09-30 $-7
2022-06-30 $-6
2022-03-31 $-9
2021-12-31 $-6
2021-09-30 $-10
2021-06-30 $-14
2021-03-31 $-16
2020-12-31 $-14
2020-09-30 $-13
2020-06-30 $-14
2020-03-31 $-15
2019-12-31 $-16
2019-09-30 $-16
2019-06-30 $-16
2019-03-31 $-16
2018-12-31 $-15
2018-09-30 $-13
2018-06-30 $-12
2018-03-31 $-13
2017-12-31 $-10
2017-09-30 $-12
2017-06-30 $-16
2017-03-31 $-18
2016-12-31 $-15
2016-09-30 $-14
2016-06-30 $-16
2016-03-31 $-15
2015-12-31 $-15
2015-09-30 $-16
2015-06-30 $-15
2015-03-31 $-14
2014-12-31 $-13
2014-09-30 $-11
2014-06-30 $-11
2014-03-31 $-9
2013-12-31 $-7
2013-09-30 $-8
2013-06-30 $-7
2013-03-31 $-5
2012-12-31 $-3
2012-09-30 $-4
2012-06-30 $-5
2012-03-31 $-4
2011-12-31 $-3
2011-09-30 $-3
2011-06-30 $-5
2011-03-31 $-4
2010-12-31 $-4
2010-09-30 $-3
2010-06-30 $-3
2010-03-31 $-4
2009-12-31 $-5
2009-09-30 $-6
2009-06-30 $-5
2009-03-31 $-7
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.250B $0.180B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $224.526B 27.00
Boston Scientific (BSX) United States $152.309B 38.13
Stryker (SYK) United States $147.916B 30.93
EssilorLuxottica (ESLOY) France $129.703B 0.00
Medtronic (MDT) Ireland $109.157B 15.94
Lonza Group Ag (LZAGY) Switzerland $49.583B 0.00
Haleon (HLN) United Kingdom $47.109B 26.80
ResMed (RMD) United States $36.312B 27.27
GE HealthCare Technologies (GEHC) United States $33.806B 16.05
Agilent Technologies (A) United States $32.907B 21.74
Terumo (TRUMY) Japan $27.953B 0.00
Koninklijke Philips (PHG) Netherlands $22.765B 16.36
Insulet (PODD) United States $22.130B 86.87
Zimmer Biomet Holdings (ZBH) United States $19.288B 12.39
Baxter (BAX) United States $15.985B 11.94
Smith & Nephew SNATS (SNN) United Kingdom $12.381B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $7.091B 23.97
Lantheus Holdings (LNTH) United States $5.462B 13.78
Prestige Consumer Healthcare (PBH) United States $4.298B 19.20
Perrigo (PRGO) Ireland $3.605B 9.14
ICU Medical (ICUI) United States $3.534B 26.06
Haemonetics (HAE) United States $3.473B 15.13
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.154B 26.21
QuidelOrtho (QDEL) United States $2.401B 16.52
GN Store Nord (GNNDY) Denmark $2.164B 17.92
LeMaitre Vascular (LMAT) United States $1.882B 42.06
AtriCure (ATRC) United States $1.558B 0.00
Neogen (NEOG) United States $1.409B 18.03
AdaptHealth (AHCO) United States $1.217B 12.36
Kestra Medical Technologies (KMTS) United States $1.179B 0.00
Green Thumb Industries (GTBIF) United States $1.172B 26.35
BioLife Solutions (BLFS) United States $1.097B 0.00
InMode (INMD) Israel $1.038B 9.50
Phibro Animal Health (PAHC) United States $0.996B 12.75
Evolus (EOLS) United States $0.653B 0.00
CeriBell (CBLL) United States $0.600B 0.00
Curaleaf Holdings (CURLF) Canada $0.577B 0.00
Owens & Minor (OMI) United States $0.559B 4.63
Valneva SE (VALN) France $0.534B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.524B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Surmodics (SRDX) United States $0.398B 0.00
Cresco Labs (CRLBF) United States $0.350B 0.00
SNDL (SNDL) Canada $0.347B 0.00
Capricor Therapeutics (CAPR) United States $0.333B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Sanara MedTech (SMTI) United States $0.312B 0.00
VAREX IMAGING (VREX) United States $0.309B 11.36
Aurora Cannabis (ACB) Canada $0.290B 51.60
Sanuwave Health (SNWV) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.97
Canopy Growth (CGC) Canada $0.267B 0.00
Omeros (OMER) United States $0.258B 0.00
Verano Holdings (VRNOF) United States $0.255B 0.00
ZimVie (ZIMV) United States $0.248B 11.28
Biote (BTMD) United States $0.214B 6.02
OraSure Technologies (OSUR) United States $0.198B 0.00
High Tide (HITI) Canada $0.186B 0.00
Brainsway (BWAY) Israel $0.185B 49.05
Quanterix (QTRX) United States $0.180B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.47
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.148B 18.19
Jin Medical (ZJYL) China $0.133B 0.00
Exagen (XGN) United States $0.120B 0.00
TerrAscend (TSNDF) Canada $0.116B 0.00
Agape ATP (ATPC) $0.101B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Fonar (FONR) United States $0.077B 10.71
Veru (VERU) United States $0.076B 0.00
Quipt Home Medical (QIPT) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Zynex (ZYXI) United States $0.066B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.037B 0.00
Safety Shot (SHOT) United States $0.034B 0.00
Nephros (NEPH) United States $0.023B 0.00
INLIF (INLF) $0.020B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00